Title:
ANTIBODY FRAGMENT AGAINST FAP
Document Type and Number:
WIPO Patent Application WO/2022/053651
Kind Code:
A3
Abstract:
The present invention relates to the field of antibody fragments, which specifically binds an epitope of human and/or murine FAP and which may be linked to an entity such as a moiety. The antibody fragment and the compound formed may be used for therapy or diagnostic purposes.
Inventors:
LAHOUTTE TONY (BE)
DEVOOGDT NICK (BE)
D'HUYVETTER MATTHIAS (BE)
MASSA SAM (BE)
DEVOOGDT NICK (BE)
D'HUYVETTER MATTHIAS (BE)
MASSA SAM (BE)
Application Number:
PCT/EP2021/075009
Publication Date:
April 21, 2022
Filing Date:
September 10, 2021
Export Citation:
Assignee:
PRECIRIX N V (BE)
International Classes:
C07K16/30; A61K39/00; A61K51/10; C07K16/40
Domestic Patent References:
| WO2019152979A1 | 2019-08-08 |
Foreign References:
| US20180092951A1 | 2018-04-05 | |||
| CN106928365A | 2017-07-07 |
Other References:
BROCKS BODO ET AL: "Species-Crossreactive scFv Against the Tumor Stroma Marker "Fibroblast Activation Protein" Selected by Phage Display From an Immunized FAP ?/? Knock-Out Mouse", MOLECULAR MEDICINE, 1 January 2001 (2001-01-01), pages 461 - 469, XP055778933, Retrieved from the Internet [retrieved on 20210223]
Attorney, Agent or Firm:
NEDERLANDSCH OCTROOIBUREAU (NL)
Download PDF: